EMD-28759
Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385
EMD-28759
Single-particle1.9 Å
Deposition: 03/11/2022Map released: 02/08/2023
Last modified: 23/10/2024
Sample Organism:
Homo sapiens,
Lama glama
Sample: human amylin 3 receptor in complex with Gs protein and San385 peptide
Fitted models: 8f0k
Deposition Authors: Cao J
,
Sexton PM ,
Wootten DL
Sample: human amylin 3 receptor in complex with Gs protein and San385 peptide
Fitted models: 8f0k
Deposition Authors: Cao J
,
Sexton PM ,
Wootten DL
Structural insight into selectivity of amylin and calcitonin receptor agonists.
Cao J ,
Belousoff MJ ,
Gerrard E,
Danev R ,
Fletcher MM,
Dal Maso E,
Schreuder H ,
Lorenz K,
Evers A,
Tiwari G ,
Besenius M,
Li Z,
Johnson RM,
Wootten D ,
Sexton PM
(2024) Nat Chem Biol , 20 , 162 - 169
,
Belousoff MJ ,
Gerrard E,
Danev R ,
Fletcher MM,
Dal Maso E,
Schreuder H ,
Lorenz K,
Evers A,
Tiwari G ,
Besenius M,
Li Z,
Johnson RM,
Wootten D ,
Sexton PM
(2024) Nat Chem Biol , 20 , 162 - 169
Grant Support:
- Australian Research Council (ARC): IC200100052 (Australia)
- National Health and Medical Research Council (NHMRC, Australia): 1120919 (Australia)
- National Health and Medical Research Council (NHMRC, Australia): 1159006 (Australia)
- National Health and Medical Research Council (NHMRC, Australia): 1150083 (Australia)
- National Health and Medical Research Council (NHMRC, Australia): 1154434 (Australia)
- National Health and Medical Research Council (NHMRC, Australia): 1155302 (Australia)
- Japan Science and Technology: 18069571 (Japan)
- Takeda Science Foundation: 2019 Medical Research Grant (Japan)